Catalyst Pharmaceuticals, Inc.
CPRXDelisted Jul 15, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001369568
Catalyst Pharmaceuticals, Inc. was delisted on Jul 15, 2026; its insiders filed their last Form 4 on Jul 17, 2026; 395 institutions reported holding it in 13F filings for Q2 2026, worth $3.39B in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q4 2025
Institutional positions in Catalyst Pharmaceuticals, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 375
- +21 vs. Q3 2025
- Shares held
- 104.0M
- +1.39M (+1.4%) vs. Q3 2025
- Total value
- $2.43B
- +$404.0M (+20.0%) vs. Q3 2025
- New holders
- 65
- 126 more added
- Sold out
- 44
- 127 more reduced
6 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CPRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 395 | $3.39B |
| Q1 2026 | 382 | $2.59B |
| Q4 2025 | 375 | $2.43B |
| Q3 2025 | 360 | $2.04B |
| Q2 2025 | 365 | $2.20B |
| Q1 2025 | 370 | $2.37B |
| Q4 2024 | 336 | $2.04B |
| Q3 2024 | 316 | $1.90B |
| Q2 2024 | 271 | $1.50B |
| Q1 2024 | 268 | $1.53B |
| Q4 2023 | 259 | $1.42B |
| Q3 2023 | 256 | $948.8M |
| Q2 2023 | 248 | $1.11B |
| Q1 2023 | 260 | $1.47B |
| Q4 2022 | 257 | $1.56B |
| Q3 2022 | 229 | $1.09B |
| Q2 2022 | 190 | $531.7M |
| Q1 2022 | 186 | $585.5M |
| Q4 2021 | 164 | $446.7M |
| Q3 2021 | 144 | $345.1M |
| Q2 2021 | 139 | $376.6M |
| Q1 2021 | 133 | $312.0M |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Catalyst Pharmaceuticals, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Persistent Asset Partners Ltd | 0 | $0 | 0.00% | −11,441−100.0% | Sold out |
| Trust Co of Oklahoma | 0 | $0 | 0.00% | −10,952−100.0% | Sold out |
| MQS Management LLC | 0 | $0 | 0.00% | −10,156−100.0% | Sold out |
| XML Financial, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Financial Life Planners | 0 | $0 | 0.00% | −2,124−100.0% | Sold out |
| Quarry LP | 0 | $0 | 0.00% | −2,011−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −2,002−100.0% | Sold out |
| ISAM Funds (UK) Ltd | 0 | $0 | 0.00% | −1,054−100.0% | Sold out |
| Optiver Holding B.V. | 0 | $0 | 0.00% | −364−100.0% | Sold out |
| Sunbelt Securities, Inc. | 0 | $0 | 0.00% | −300−100.0% | Sold out |
| Wealth Watch Advisors, INC | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| Mather Group, LLC. | 0 | $0 | 0.00% | −132−100.0% | Sold out |
| Cloud Capital Management, LLC | 0 | $0 | 0.00% | −70−100.0% | Sold out |
| Principal Securities, Inc. | 0 | $0 | 0.00% | −38−100.0% | Sold out |
| Atlantic Trust, LLC | 0 | $0 | 0.00% | −22−100.0% | Sold out |
| Montag A & Associates Inc | 0 | $0 | 0.00% | −18−100.0% | Sold out |
| JPL Wealth Management, LLC | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| Grey Fox Wealth Advisors, LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Newbridge Financial Services Group, Inc. | 0 | $0 | 0.00% | 0 | Sold out |
| Glenmede Investment Management, LP | – | – | – | – | Not filed |
| Lokken Investment Group LLC | – | – | – | – | Not filed |
| CIBC Bancorp USA Inc. | – | – | – | – | Not filed |
| Shell Asset Management Co | – | – | – | – | Not filed |
| Guerra Advisors Inc | – | – | – | – | Not filed |
| Hemington Wealth Management | – | – | – | – | Not filed |